You are here

BETASTEM THERAPUETICS, INC.

Company Information
Address
BETASTEM THERAPUETICS, INC. 665 Third Street
SAN FRANCISCO, CA 94107
United States



Information

UEI: MK9RVWH59CV3

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Autologous TGFB Modified CD Stem Cells for Repair of Diabetic Macular Edema and Macular Ischemia

    Amount: $461,417.00

    Autologous TGFB Modified CD Stem Cells for Repair of Diabetic Macular Edema and Macular Ischemia Retinal vascular diseases such as diabetic macular edema and macular ischemia remain ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  2. Accelerated Repair of Vascular Injury in Diabetes by TGF-beta Modified Stem Cells

    Amount: $284,989.00

    DESCRIPTION (provided by applicant): Accelerated Repair of Vascular Injury in Diabetes by TGF-beta Modified Stem Cells Abstract: Stem cells of hematopoietic origin (HSC) have been described that have ...

    SBIRPhase I2009Department of Health and Human Services National Institutes of Health
  3. Autologous TGF-B-Modified HSC for Repair of Vasodegenerative Diabetic Retinopathy

    Amount: $326,697.00

    DESCRIPTION (provided by applicant): Diabetic retinopathy induces retinal vascular endothelial damage resulting in ischemia, edema, and hemorrhage. Current available treatments for diabetic retinopath ...

    SBIRPhase I2009Department of Health and Human Services National Institutes of Health
  4. Progenitor assay to screen proteins/molecules for treatment of type1 diabetes

    Amount: $198,752.00

    DESCRIPTION (provided by applicant): Human embryonic stem cells (HuES) have the potential to generate an unlimited source of beta/islet cells for transplantation, however the biologic factors required ...

    STTRPhase I2007Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government